Skip to main content Skip to search Skip to main navigation
About-JPT

JPT Peptide Technologies

Enabling researchers with precise, reliable solutions for immunology,
proteomics, drug discovery, and next-generation therapies. 
We aim to shape the future of peptide technologies by turning 
scientific ambition into practical progress, helping our partners 
move faster from insight to impact.


JPT Peptide Technologies is a leading German company based in Berlin. Founded in 2004 as a spin-off from Jerini AG, the company’s name reflects its origins: the “J” in JPT stands for Jerini.

From the beginning, JPT was built around its proprietary ultra-high-throughput SPOT peptide synthesis technology. This platform enables the parallel production of exceptionally large numbers of peptides, from thousands per machine to millions per year. The peptides appear as blue dots on the SPOT membrane, a distinctive visual feature that inspired JPT’s original logo.

This capability became especially significant in the 2000s, following the completion of the Human Genome Project, when the scientific focus increasingly shifted from mapping genes to understanding proteins. In this context, JPT played an important role in the Human Proteome Sequencing Project, contributing peptide technologies that supported efforts to decode the human proteome. 
JPT logo redesign

In 2025, JPT updated its logo and corporate design to modernize the brand and reinforce the company’s identity as a peptide manufacturer. The new logomark represents an amide bond in formation, reflecting the chemistry at the heart of peptide synthesis.

Discover The JPT's Journey!


JPT's Portfolio

Our Portfolio

JPT has developed a unique portfolio of proprietary peptide products,
services, and technologies, supported by extensive production
capacities and an unwavering commitment to quality, establishing the company as a leader in peptide production. Among its key innovations
is PepMix™, a peptide mixture designed to replace full-length proteins, which has become a gold standard for T-cell activation in vaccine research and clinical trials. Over time, JPT has expanded its portfolio to include peptide libraries such as PepTrack, peptides for proteomics
such as SpikeTides, immobilized peptides such as PepStar, and,
more recently, peptides for gene therapy, including Travirtide. During
the COVID-19 pandemic, JPT was highly active and once again became
the first provider of a critical reagent, the SARS-CoV-2 Spike PepMix,
which contributed to the rapid testing of vaccine efficacy.

Discover Our Products and Services!


Mission-Berlin

Our Mission

At JPT Peptide Technologies, our mission is to achieve customer satisfaction through excellence
and innovation. With a strong focus on preclinical and clinical research, we have served
more than 20,000 clients worldwide. Having produced several million peptides,
received thousands of citations in peer-reviewed publications, and maintained
ISO 9001 certification since 2004, JPT has built unique expertise and a strong reputation
in the field of peptide technologies.




JPT_Team

Our Team

The JPT team comprises over 100 employees at its headquarters in Berlin and its office in the United States. More than 60% of our team has a scientific background, including over 20 PhD-level experts. Our technical operations team brings together specialists in peptide and organic chemistry, purification, analytical chemistry, data management, instrumentation, method development, and quality assurance. Our commercial team ensures careful project evaluation and management, as well as reliable after-sales technical support. Experienced in working with scientists from over 100 countries, our team speaks more than 10 languages and is dedicated to supporting customers worldwide.


Meet the JPT Team!

Our Facility

Welcome to the he House of Peptides (HoP)! The JPT’s brand new manufacturing site opened in Adlershof Technology Park in south East Berlin in 2025. With more than 8,000 sqm (90,000 sqft), this state-of-the art facility enables efficient peptide production by incorporating specialized laboratories for chemistry andbiology (S2 lab), an ISO8 clean room, multiple automated processes, optimized workflows, comprehensive temperature and humidity control, and redundant systems for business continuity. The infrastructure was also designed to ensure a high level of safety for employees and provide a comfortable working environment. Environmental impact was considered from the beginning of the construction planning and LEED certification is ongoing.  

   Our Facility

      Welcome to the he House of Peptides (HoP)! The JPT’s brand new
      manufacturing site opened in Adlershof Technology Park in south
      East Berlin in 2025. With more than 8,000 sqm (90,000 sqft), this
      state-of-the art facility enables efficient peptide production by
      incorporating specialized laboratories for chemistry andbiology
      (S2 lab), an ISO8 clean room, multiple automated processes,
      optimized workflows, comprehensive temperature and humidity
      control, and redundant systems for business continuity.
      The infrastructure was also designed to ensure a high level of safety
      for employees and provide a comfortable working environment.
      Environmental impact was considered from the beginning of the
      construction planning and LEED certification is  ongoing.

JPT's Portfolio


Get Onboard and Discover JPT:

Check our list of products, click and go.

Get a quote